Stryker Corporation, commonly referred to as Stryker, is a leading global medical technology company headquartered in the United States. Founded in 1941, Stryker has established itself as a key player in the orthopaedics, surgical equipment, and neurotechnology sectors, with significant operations across North America, Europe, and Asia-Pacific. The company is renowned for its innovative products, including advanced surgical instruments, implantable devices, and patient handling solutions, which are designed to enhance surgical outcomes and improve patient care. Stryker's commitment to quality and innovation has positioned it as a trusted partner in the healthcare industry, earning numerous accolades for its contributions to medical technology. With a strong market presence, Stryker continues to lead the way in developing cutting-edge solutions that address the evolving needs of healthcare professionals and patients alike.
How does Stryker's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Stryker's score of 36 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2023, Stryker Corporation reported total emissions of approximately 54,854,000 kg CO2e for Scope 1 and about 81,619,000 kg CO2e for Scope 2, resulting in a combined total of approximately 136,473,000 kg CO2e. This data highlights Stryker's ongoing commitment to reducing its carbon footprint, particularly in the healthcare equipment and supplies sector. Stryker has set ambitious targets to achieve a 20% reduction in Scope 1 and Scope 2 emissions by 2024, using a 2019 baseline. This interim goal reflects their proactive approach to sustainability. Furthermore, the company aims to reach carbon neutrality for both Scope 1 and Scope 2 emissions by 2030, demonstrating a long-term commitment to environmental responsibility. In 2022, Stryker's emissions included approximately 57,383,000 kg CO2e for Scope 1 and 117,059,000 kg CO2e for Scope 2, indicating a significant focus on managing direct and indirect emissions. The absence of Scope 3 emissions data suggests that Stryker is still developing strategies to address these broader impacts. Overall, Stryker's climate commitments and reduction initiatives position the company as a leader in sustainability within the healthcare sector, aiming for substantial emissions reductions in the near future.
Access structured emissions data, company-specific emission factors, and source documents
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Scope 1 | - | 00,000,000 | - | - | 00,000,000 |
Scope 2 | 146,705,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 |
Scope 3 | - | - | - | - | - |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Stryker is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.